Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 602 record(s)

Req # A-2019-002076

Adverse Drug Reaction (ADR). Report number: E2B_02697540.

Organization: Health Canada

26 page(s)
October 2023

Req # A-2020-000305

Adverse Drug Reactions (ADRs). Report numbers: E2B_02333532, E2B_02413346, E2B_02281231, E2B_02638001, E2B_02671175, E2B_02682842,E2B_02740843, E2B_02778702, E2B_02786752.

Organization: Health Canada

209 page(s)
October 2023

Req # A-2020-000549

Adverse Drug Reactions (ADRs) for METRONIDAZOLE. Report numbers: E2B_02831793, E2B_02825695, E2B_02848902, E2B_02955574, 734688, E2B_02818493, E2B_02903607, E2B_02909180.

Organization: Health Canada

105 page(s)
October 2023

Req # A-2021-001718

Adverse Drug Reactions (ADRs) for ZOPICLONE. Report numbers: E2B_04368872, E2B_03380105.

Organization: Health Canada

58 page(s)
October 2023

Req # A-2021-001726

Adverse Drug Reactions (ADRs) for ZOPICLONE. Report numbers: 000957304, 000962869.

Organization: Health Canada

5 page(s)
October 2023

Req # A-2022-000189

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-075758-82.

Organization: Health Canada

5 page(s)
October 2023

Req # A-2022-000194

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-117522-158.

Organization: Health Canada

5 page(s)
October 2023

Req # A-2022-001204

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-110754-450.

Organization: Health Canada

17 page(s)
October 2023

Req # A-2022-001449

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075392-765.

Organization: Health Canada

14 page(s)
October 2023

Req # A-2023-000244

Adverse Drug Reactions (ADRs). Report numbers: 001024930, E2B_05783579, E2B_06069740, E2B_06080220, E2B_06069484, E2B_02587472, E2B_02571933, E2B_05925115, 001025372, E2B_06061678.

Organization: Health Canada

699 page(s)
October 2023
Date modified: